ECM
INSM icon

Everence Capital Management’s Insmed INSM Stock Holding History

Everence Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Sell
6,384
-390
-6% -$60K 0.06% 235
2025
Q4 		$1.18M Buy
6,774
+331
+5% +$60.4K 0.07% 216
2025
Q3 		$928K Buy
6,443
+1,343
+26% +$165K 0.06% 253
2025
Q2 		$513K Hold
5,100
– – 0.03% 373
2025
Q1 		$389K Hold
5,100
– – 0.03% 446
2024
Q4 		$352K Buy
+5,100
New +$367K 0.02% 501

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Everence Capital Management's INSM Position: Q1 2026 in Review

Everence Capital Management reduced its Insmed (INSM) stake by 5.8% in Q1 2026, selling an estimated $60K and leaving 6,384 shares worth $1.04M. The position accounts for 0.06% of the portfolio, ranked #235.

Everence Capital Management first reported a position in INSM in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.18M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Everence Capital Management held 6,384 shares of Insmed worth $1.04M as of Q1 2026.
  • Everence Capital Management sold 390 Insmed shares in Q1 2026, an estimated $60K.
  • Insmed made up 0.06% of Everence Capital Management's portfolio in Q1 2026, its #235 holding.
  • Everence Capital Management first reported a position in Insmed in Q4 2024 and has held it in 6 quarters since.
  • Everence Capital Management's Insmed position peaked at $1.18M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.